Topic

New Jersey

A collection of 536 issues

How to Get Kanuma (Sebelipase Alfa) Covered by Aetna CVS Health in New Jersey: Complete Decision Tree & Appeals Guide

Quick Answer: Kanuma requires prior authorization from Aetna CVS Health for LAL-D treatment in New Jersey. You'll need confirmed enzyme deficiency (LAL activity testing) plus genetic confirmation (LIPA variants), clinical evidence of disease severity, and proper documentation. If denied, New Jersey's IHCAP external review through Maximus

How to Get Defitelio (Defibrotide) Covered by Cigna in New Jersey: Complete PA Guide and Appeals Process

Answer Box: Getting Defitelio Covered by Cigna in New Jersey Defitelio (defibrotide) requires prior authorization from Cigna for hepatic VOD/SOS with organ dysfunction post-stem cell transplant. Your transplant physician should call Cigna at 1-800-882-4462 for expedited 72-hour approval. If denied, you have 180 days to file internal appeals, then

How to Get Ibrance (Palbociclib) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization Guide

Quick Answer: Getting Ibrance (Palbociclib) Covered by Aetna CVS Health in New Jersey Ibrance requires prior authorization from Aetna CVS Health as a Tier 4/5 specialty drug for HR+/HER2- metastatic breast cancer. Your oncologist submits the PA with pathology confirming hormone receptor status, treatment history, and combination therapy

The Requirements Checklist to Get Soliris (Eculizumab) Covered by Humana in New Jersey

Answer Box: Getting Soliris (Eculizumab) Covered by Humana in New Jersey Soliris (eculizumab) requires prior authorization from Humana Medicare Advantage plans in New Jersey. The fastest path to approval: (1) Verify active coverage and submit via CenterWell Specialty Pharmacy with complete clinical documentation, (2) Include meningococcal vaccination records and FDA-approved

Skyrizi (Risankizumab) Approval with Blue Cross Blue Shield in New Jersey: Complete Guide to Prior Authorization, Appeals, and Coverage

Quick Answer: Getting Skyrizi Covered by Blue Cross Blue Shield in New Jersey Horizon Blue Cross Blue Shield of New Jersey requires prior authorization for Skyrizi (risankizumab), a specialty medication. Start by having your prescriber submit a PA request through the Horizon provider portal within 72 hours for standard approval.

Myths vs. Facts: Getting Eylea and Lucentis Covered by UnitedHealthcare in New Jersey

Quick Answer: UnitedHealthcare requires prior authorization for Eylea and Lucentis in New Jersey, with step therapy typically mandating bevacizumab failure first. If denied, you have 180 days for internal appeals, then can file for external review through New Jersey's IHCAP program administered by Maximus Federal Services. Start by

How to Get Carbaglu (Carglumic Acid) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Carbaglu Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Carbaglu (carglumic acid) in New Jersey, with 12-month approvals for documented hyperammonemia due to NAGS deficiency, propionic acidemia, or methylmalonic acidemia. Submit through the UHC/OptumRx provider portal with genetic testing, elevated ammonia labs, and

How to Get Mepsevii (vestronidase alfa-vjbk) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and Renewal Guide

Answer Box: Getting Mepsevii Covered by Cigna in New Jersey Mepsevii (vestronidase alfa-vjbk) requires prior authorization from Cigna nationwide, including New Jersey. To get approval, you need: (1) confirmed MPS VII diagnosis via enzyme deficiency test or genetic testing, (2) prescription from a metabolic specialist, and (3) clinical documentation showing

How to Get Pomalyst (pomalidomide) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pomalyst Covered by Blue Cross Blue Shield in New Jersey Pomalyst (pomalidomide) requires prior authorization from Blue Cross Blue Shield plans in New Jersey for multiple myeloma treatment. To get approved: (1) Ensure your oncologist documents prior lenalidomide and proteasome inhibitor failures with progression within 60 days,

Myths vs. Facts: Getting Brensocatib (BRINSUPRI) Covered by Aetna (CVS Health) in New Jersey

Answer Box: Getting BRINSUPRI Covered by Aetna in New Jersey Brensocatib (BRINSUPRI) is covered by Aetna (CVS Health) in New Jersey through prior authorization when you meet specific criteria: age 12+, confirmed non-CF bronchiectasis, ≥2 exacerbations in 12 months, and documented macrolide antibiotic failure. Submit PA via CVS Caremark provider